Infants who cannot receive fresh breast milk, or whose microbiomes are disrupted by delivery mode, antibiotics or prematurity, may miss beneficial breast-milk bacteria.
R&D Focus
Breast-milk microbiome preservation, infant synbiotics and live biotherapeutic products.
Innovative Solution
The company develops a breast-milk storage device that removes oxygen to preserve sensitive beneficial bacteria and microbiome drops containing breast-milk-derived bacterial communities.
Solution Effectiveness
The storage approach is designed to preserve the natural breast-milk microbiome and extend milk shelf life; peer-reviewed efficacy data were still planned before commercial launch in the latest reviewed reporting.
Investment Funding
Last Funding Stage
Grant
Total Funding Amount
4.09M
Last Funding Amount
2.1M
Last Funding Date
22-08-2024
Startup Stage
Seed
Lead Investors
Innovate UK, Venrex, Discovery Park, Simon Galbraith
Revenue
$1M to $10M
People
Founders
Lydia Mapstone
Sioned Jones
Tara O'Driscoll
About
BoobyBiome uses specialist expertise and research to develop a probiotic supplement for infants with compromised microbiomes. They aim to promote healthy infant development by recreating the beneficial bacteria associated with breast milk.
Products
Product
Oxygen-removing breast-milk storage device; infant microbiome drops/live biotherapeutic product based on beneficial breast-milk bacteria.
Star Product
Breast-milk storage device, because it became the first product targeted for market entry.
Demo Product or Complete Product?
Pre-commercial. In September 2025, the storage device was planned for launch within six months and the microbiome drops were being advanced toward clinical trials and a later launch.
Future Plan
Investment Funding
Raised £1.3 million in equity and grant funding by 2022; announced a £2.5 million seed round in 2025 led by Empirical Ventures. Discovery Park Ventures invested £100,000 in the earlier round.
Awards and Recognitions
Participations
BIA PULSE candidate; visibility and recognition displayed from Forbes, Sifted and Hurun.
Media Apperance
Featured in The Times in 2025 for its breast-milk preservation technology.
M&A and Collabs
Collab
Centre for Process Innovation: process development and assembly of bacterial species into a live biotherapeutic infant product.
Something missing or incorrect on this page? Help us enrich this information
